Xencor Appoints Bart Cornelissen as Chief Financial Officer

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart Cornelissen [alumnus RSM MScBA] to senior vice president and chief financial officer.

Read the article: https://www.placera.se/placera/pressmeddelanden/2024/04/09/xencor-xencor-appoints-bart-cornelissen-as-chief-financial-officer.html

Participants

  • Bart Cornelissen
    Role: Alumni
    Reference type: Featured

Media Outlets

  • Placera (Online)